Lanreotide, extended-release solution for injection, 120 mg/syringe, 0.5 ml

By: Iryna Sklez๐Ÿ“ UkraineOpen

Key Information

ReferenceGB-UA-2026-11-17-013760-a
DeadlineNov 20, 2026 12:00 AM
Estimated ValueUAH 39,990,000.00
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryUkraine
Address44500, Ukraine, Volyn region, Kamin-Kashirskyi district, Kamin-Kashirskyi, st.Shevchenko, building43
PublishedNov 17, 2026

Description

Lanreotide, extended-release solution for injection, 120 mg/syringe, 0.5 ml

Full details are available after unlocking this tender.